Company Overview of Yale Cancer Center
Key Executives for Yale Cancer Center
Compensation as of Fiscal Year 2013.
Yale Cancer Center Key Developments
Yale Cancer Center Presents at Leerink Swann Global Healthcare Conference, Feb-13-2013 09:30 AM
Feb 7 13
Yale Cancer Center Presents at Leerink Swann Global Healthcare Conference, Feb-13-2013 09:30 AM. Venue: Waldorf Astoria Hotel, New York, New York, United States. Speakers: Roy Herbst, M.D., Ph.D.
Yale Cancer Center Presents at 3rd Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference, Oct-04-2012 09:00 AM
Sep 28 12
Yale Cancer Center Presents at 3rd Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference, Oct-04-2012 09:00 AM. Venue: New York Academy of Medicine, 1216 5th Avenue (entrance is on East 103rd Street), New York, NY 10029, United States. Speakers: Daniel P. Petrylak, M.D.
Sarah Cannon Research Institute, LLC, Yale Cancer Center and Smilow Cancer Hospital Announce Scientific Collaboration to Advance Cancer Research
May 30 12
Sarah Cannon Research Institute, LLC announced the finalization of an agreement to collaborate scientifically with Yale Cancer Center (YCC) and Smilow Cancer Hospital at Yale-New Haven (SCH) to advance cancer research. As part of the collaboration, SCRI physician scientists will partner with physician scientists from Yale Cancer Center to discuss strategic scientific priorities and develop clinical research protocols. Other components of the partnership include the opening of a clinical trial management office on the Yale Cancer Center campus in New Haven, CT and for Smilow Cancer Hospital to develop a network of community-based sites that will participate in the program. SCRI's role in the management of the clinical trials office will be to provide assistance in opening research studies at Yale and within their community network, as well as to augment clinical trial availability and participation of patients in Yale's service area. SCRI offers a robust clinical research infrastructure, an expansive strategic investigator site network and a drug development program that has conducted over 100 first-in-man trials. YCC is a National Cancer Institute-designated comprehensive cancer center with a strong background in drug discovery, molecular profiling, and translational research through clinical care at Smilow Cancer Hospital.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries